SCHEMBL16410706

SCHEMBL16410706

N=CC(O)(C=N)c1cccc(CN=NC2=Nc3ccccc3NC23CCOCC3)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410767 0.82 ACAT2 (0.43) —
SCHEMBL16410726 0.82 ALDH1A1 (0.32) —
SCHEMBL16410787 0.79 ACAT2 (0.33) —
SCHEMBL16410788 0.77 ALDH1A1 (0.30) —
SCHEMBL16410728 0.77 ACAT2 (0.42) —
SCHEMBL16410789 0.75 ACAT2 (0.38) —
SCHEMBL16410766 0.75 ACAT2 (0.47) —
SCHEMBL16410617 0.73 ACAT2 (0.35) —
SCHEMBL16410816 0.72 ACAT2 (0.45) —
SCHEMBL16410830 0.71 ACAT2 (0.57) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback